HUTCHMED (China) Cash Flow Statement
NASDAQ: HCMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
14.10+0.43 (+3.15%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
HUTCHMED (China) free cash flow
In fiscal 2025, HUTCHMED (China) generated -$64.7 million of operating cash flow and spent $14.1 million on capital expenditures. That left free cash flow of -$78.8 million, a free-cash-flow margin of -14.4% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
HUTCHMED (China) cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 457.73M | 38.17M | 101.09M | -360.39M | -167.04M | -115.52M | -103.68M | -71.29M | -22.96M | 14.56M |
| Net Income growth (YoY) | +1099.19% | -62.24% | — | — | — | — | — | — | -257.75% | +39.61% |
| Depreciation & Amortization | 13.31M | 12.34M | 8.21M | 8.66M | 7.19M | 6.06M | 4.94M | 3.59M | 2.58M | 2.34M |
| Change in Working Capital | -60.86M | -62.17M | 71.15M | 58.70M | 32.46M | 29.27M | 16.11M | 7.16M | -14.51M | 3.43M |
| Operating Cash Flow | -64.66M | 497.00K | 219.26M | -268.60M | -204.22M | -62.07M | -80.91M | -32.85M | -8.94M | -9.57M |
| Capital Expenditures | -14.15M | -17.93M | -32.61M | -36.66M | -16.40M | -7.95M | -8.56M | -6.36M | -5.02M | -4.33M |
| Investing Cash Flow | -29.41M | -96.06M | -291.14M | 296.59M | -306.32M | -125.44M | 119.03M | 43.75M | -260.78M | -33.60M |
| Share Repurchases | — | -36.06M | -9.07M | -48.08M | -27.31M | -12.90M | -346.00K | -5.45M | -1.37M | -604.00K |
| Financing Cash Flow | 7.84M | -30.67M | 48.66M | -82.76M | 650.03M | 296.43M | -1.49M | -8.23M | 273.20M | 92.44M |
| Net Change in Cash | -82.63M | -129.63M | -29.69M | -64.26M | 141.91M | 114.47M | 35.12M | 771.00K | 5.83M | 47.49M |
| Free Cash Flow | -78.81M | -17.44M | 186.65M | -305.26M | -220.62M | -70.02M | -89.48M | -39.21M | -13.96M | -13.90M |
This table shows 10 annual periods of HUTCHMED (China)'s cash flow statement, from FY 2025 back to FY 2016, across 10 line items including net income, depreciation & amortization, change in working capital. Values in USD; B = billions, M = millions. Fiscal periods follow HCM's reporting calendar. What is a cash flow statement?